4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-20-003052
Options or other derivatives
- SVP, Chief Financial Officer acquired 153,631 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sun Elaine D · SVP, Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-03-02 | Grant or award : show line 1 in the form Option to Purchase Common Stock | +104,969 | $20.55 | 2030-03-02 | 104,969 | 104,969 | D |
| 2020-03-02 | Grant or award : show line 2 in the form Restricted Stock Units | +48,662 | $0.00 | 2030-03-02 | 48,662 | 48,662 | D |
Loading xslF345X03/edgar.xml…